MA26662A1 - Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation - Google Patents

Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation

Info

Publication number: MA26662A1
Authority: MA; Morocco
Prior art keywords: pharmaceutical compositions; compositions containing; thiazolidinedione derivatives; thiazolidinedione; derivatives
Prior art date: 1998-07-21

Application number

MA25690A

Other languages

English (en)

Inventor

Dr Antoine Michel Alain Bril

Dr Robin Edwin Buckingham

Dr Nassirah Khandoudi

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-21

Filing date

1999-07-19

Publication date

2004-12-20

1998-07-21 Priority claimed from GBGB9815871.0A external-priority patent/GB9815871D0/en

1998-07-21 Priority claimed from GBGB9815872.8A external-priority patent/GB9815872D0/en

1999-07-19 Application filed by Smithkline Beecham Plc, Smithkline Beecham Lab filed Critical Smithkline Beecham Plc

2004-12-20 Publication of MA26662A1 publication Critical patent/MA26662A1/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Organic Chemistry (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Thiazole And Isothizaole Compounds (AREA)

MA25690A 1998-07-21 1999-07-19 Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation MA26662A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9815871.0A GB9815871D0 (en)	1998-07-21	1998-07-21	Novel compound
GBGB9815872.8A GB9815872D0 (en)	1998-07-21	1998-07-21	Novel method

Publications (1)

Publication Number	Publication Date
MA26662A1 true MA26662A1 (fr)	2004-12-20

Family

ID=26314086

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25690A MA26662A1 (fr)	1998-07-21	1999-07-19	Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation

Country Status (35)

Country	Link
EP (2)	EP1098638B1 (fr)
JP (1)	JP2002521325A (fr)
KR (1)	KR20010079550A (fr)
CN (1)	CN1167416C (fr)
AP (1)	AP1416A (fr)
AR (1)	AR020614A1 (fr)
AT (1)	ATE318588T1 (fr)
AU (1)	AU5053599A (fr)
BG (1)	BG105251A (fr)
BR (1)	BR9912144A (fr)
CA (1)	CA2338216A1 (fr)
CO (1)	CO5060465A1 (fr)
CY (1)	CY1106078T1 (fr)
CZ (1)	CZ2001250A3 (fr)
DE (1)	DE69930125T2 (fr)
DK (1)	DK1098638T3 (fr)
DZ (1)	DZ2854A1 (fr)
EA (1)	EA004772B1 (fr)
ES (1)	ES2259839T3 (fr)
GC (1)	GC0000173A (fr)
HU (1)	HUP0103870A3 (fr)
ID (1)	ID27850A (fr)
IL (1)	IL140741A0 (fr)
MA (1)	MA26662A1 (fr)
NO (1)	NO20010293L (fr)
NZ (1)	NZ509175A (fr)
OA (1)	OA11583A (fr)
PE (1)	PE20000881A1 (fr)
PL (1)	PL345663A1 (fr)
PT (1)	PT1098638E (fr)
SI (1)	SI1098638T1 (fr)
SK (1)	SK1022001A3 (fr)
TR (1)	TR200100208T2 (fr)
TW (2)	TWI239836B (fr)
WO (1)	WO2000004889A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1206457E (pt)	1999-08-27	2004-03-31	Lilly Co Eli	Derivados de diaril-oxa(tia)zol e seu uso como moduladores dos ppars
EA200300028A1 (ru) *	2000-06-16	2003-04-24	Смитклайн Бичам Плс	Лечение и профилактика состояний, ассоциированных с сердечной инсулинорезистентностью
WO2003009807A2 (fr)	2001-07-23	2003-02-06	Galileo Laboratories, Inc.	Composes cytoprotecteurs, procedes et formulations pharmaceutiques et cosmetiques

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG59988A1 (en) *	1987-09-04	1999-02-22	Beecham Group Plc	Substituted thiazolidinedione derivatives
JPH05202042A (ja) *	1992-01-24	1993-08-10	Sankyo Co Ltd	糖尿病性合併症治療剤
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
GB9611947D0 (en) *	1996-06-07	1996-08-07	Glaxo Group Ltd	Medicaments
US6277819B1 (en) *	1996-08-30	2001-08-21	Eli Lilly And Company	Use of GLP-1 or analogs in treatment of myocardial infarction
KR20000036035A (ko) *	1996-09-12	2000-06-26	가와무라 요시부미	트로글리타존을 함유하는 글루타티온 환원효소 활성증강제
DE69834508T2 (de) *	1997-11-19	2006-11-23	Takeda Pharmaceutical Co. Ltd.	Apoptoseinhibitoren
AU2781899A (en) *	1998-02-24	1999-09-15	Trustees Of The University Of Pennsylvania, The	Use of a cardiac purinoceptor to effect cellular glucose uptake
WO1999059586A1 (fr) *	1998-05-19	1999-11-25	Regents Of The University Of California	Derives de thiazolidine et d'oxazolidine pour le traitement d'infarctus du myocarde aigus et pour l'inhibition de l'apoptose des cardiomyocytes
US5968960A (en) *	1999-01-14	1999-10-19	The Regents Of The University Of California	Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism

1999
- 1999-07-19 MA MA25690A patent/MA26662A1/fr unknown
- 1999-07-20 PE PE1999000726A patent/PE20000881A1/es not_active Application Discontinuation
- 1999-07-21 GC GCP1999211 patent/GC0000173A/en active
- 1999-07-21 EP EP99934911A patent/EP1098638B1/fr not_active Expired - Lifetime
- 1999-07-21 IL IL14074199A patent/IL140741A0/xx unknown
- 1999-07-21 BR BR9912144-1A patent/BR9912144A/pt not_active IP Right Cessation
- 1999-07-21 DK DK99934911T patent/DK1098638T3/da active
- 1999-07-21 TW TW088112356A patent/TWI239836B/zh not_active IP Right Cessation
- 1999-07-21 SK SK102-2001A patent/SK1022001A3/sk unknown
- 1999-07-21 KR KR1020017000924A patent/KR20010079550A/ko not_active Application Discontinuation
- 1999-07-21 DE DE69930125T patent/DE69930125T2/de not_active Expired - Fee Related
- 1999-07-21 CN CNB998089826A patent/CN1167416C/zh not_active Expired - Fee Related
- 1999-07-21 PL PL99345663A patent/PL345663A1/xx not_active Application Discontinuation
- 1999-07-21 ID IDW20010151A patent/ID27850A/id unknown
- 1999-07-21 OA OA1200100021A patent/OA11583A/en unknown
- 1999-07-21 AU AU50535/99A patent/AU5053599A/en not_active Abandoned
- 1999-07-21 AT AT99934911T patent/ATE318588T1/de not_active IP Right Cessation
- 1999-07-21 EA EA200100164A patent/EA004772B1/ru not_active IP Right Cessation
- 1999-07-21 AP APAP/P/2001/002033A patent/AP1416A/en active
- 1999-07-21 NZ NZ509175A patent/NZ509175A/en unknown
- 1999-07-21 WO PCT/GB1999/002358 patent/WO2000004889A1/fr not_active Application Discontinuation
- 1999-07-21 CO CO99045729A patent/CO5060465A1/es unknown
- 1999-07-21 ES ES99934911T patent/ES2259839T3/es not_active Expired - Lifetime
- 1999-07-21 CA CA002338216A patent/CA2338216A1/fr not_active Abandoned
- 1999-07-21 AR ARP990103577A patent/AR020614A1/es not_active Application Discontinuation
- 1999-07-21 HU HU0103870A patent/HUP0103870A3/hu unknown
- 1999-07-21 TW TW092103470A patent/TW200307532A/zh unknown
- 1999-07-21 PT PT99934911T patent/PT1098638E/pt unknown
- 1999-07-21 EP EP04077992A patent/EP1523980A3/fr not_active Withdrawn
- 1999-07-21 SI SI9930889T patent/SI1098638T1/sl unknown
- 1999-07-21 JP JP2000560882A patent/JP2002521325A/ja not_active Withdrawn
- 1999-07-21 CZ CZ2001250A patent/CZ2001250A3/cs unknown
- 1999-07-21 TR TR2001/00208T patent/TR200100208T2/xx unknown
- 1999-07-21 DZ DZ990154A patent/DZ2854A1/fr active
2001
- 2001-01-18 NO NO20010293A patent/NO20010293L/no unknown
- 2001-02-14 BG BG105251A patent/BG105251A/xx unknown
2006
- 2006-05-12 CY CY20061100616T patent/CY1106078T1/el unknown

Also Published As

Publication number	Publication date
PL345663A1 (en)	2002-01-02
ID27850A (id)	2001-04-26
PE20000881A1 (es)	2000-10-07
BR9912144A (pt)	2001-04-03
DK1098638T3 (da)	2006-06-19
OA11583A (en)	2004-07-01
EP1523980A2 (fr)	2005-04-20
AP1416A (en)	2005-06-13
EA200100164A1 (ru)	2001-08-27
GC0000173A (en)	2006-03-29
EP1098638B1 (fr)	2006-03-01
KR20010079550A (ko)	2001-08-22
JP2002521325A (ja)	2002-07-16
CZ2001250A3 (cs)	2002-03-13
DZ2854A1 (fr)	2003-12-01
TWI239836B (en)	2005-09-21
EP1098638A1 (fr)	2001-05-16
TR200100208T2 (tr)	2001-05-21
CA2338216A1 (fr)	2000-02-03
AU5053599A (en)	2000-02-14
NO20010293L (no)	2001-03-07
HUP0103870A2 (hu)	2002-05-29
EA004772B1 (ru)	2004-08-26
PT1098638E (pt)	2006-07-31
TW200307532A (en)	2003-12-16
DE69930125D1 (de)	2006-04-27
EP1523980A3 (fr)	2009-03-18
DE69930125T2 (de)	2006-10-05
NO20010293D0 (no)	2001-01-18
NZ509175A (en)	2003-10-31
BG105251A (en)	2001-10-31
ATE318588T1 (de)	2006-03-15
ES2259839T3 (es)	2006-10-16
CY1106078T1 (el)	2011-06-08
CO5060465A1 (es)	2001-07-30
SI1098638T1 (sl)	2006-06-30
AR020614A1 (es)	2002-05-22
IL140741A0 (en)	2002-02-10
HUP0103870A3 (en)	2003-06-30
CN1310619A (zh)	2001-08-29
AP2001002033A0 (en)	2001-03-31
SK1022001A3 (en)	2001-08-06
CN1167416C (zh)	2004-09-22
WO2000004889A1 (fr)	2000-02-03

Publication	Publication Date	Title
DZ2964A1 (fr)	2004-03-15	Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2805818B1 (fr)	2002-04-26	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
MA26537A1 (fr)	2004-12-20	Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
MA26443A1 (fr)	2004-12-20	Aralkyl- et aralkylidene-lactames et -imides heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
HUP0203973A3 (en)	2004-07-28	Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26453A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2 amine et compositions pharmaceutiques les contenant
FR2732967B1 (fr)	1997-07-04	1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
MA26553A1 (fr)	2004-12-20	Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
MA26685A1 (fr)	2004-12-20	Derives d'azetidine leur preparation et les medicaments les contenant
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2789388B1 (fr)	2005-11-18	Composes stabilisants, composition les contenant et leur utilisation
DZ2086A1 (fr)	2002-07-22	Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
FR2807038B1 (fr)	2002-08-16	Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
MA26491A1 (fr)	2004-12-20	Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .
MA26422A1 (fr)	2004-12-20	Derives de quinoxalinedone, procedes et intermediaires pour leur preparation, et compositions pharmaceutiques les contenant.
FR2761066B1 (fr)	2000-11-24	Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
EE9800426A (et)	1999-06-15	Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid
FR2779724B1 (fr)	2001-04-20	Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2681067B1 (fr)	1993-12-17	Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
FR2796380B3 (fr)	2001-08-17	Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
FR2795733B1 (fr)	2001-09-07	Derives de streptogramines, leur preparation et les compositions qui les contiennent
MA26609A1 (fr)	2004-12-20	Derives de retiferol, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation